Previous close | 107.59 |
Open | 107.59 |
Bid | 121.40 |
Ask | 130.60 |
Strike | 310.00 |
Expiry date | 2024-06-21 |
Day's range | 107.59 - 107.59 |
Contract range | N/A |
Volume | |
Open interest | 3 |
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...